Search

Your search keyword '"Massuti, Bartomeu"' showing total 11 results

Search Constraints

Start Over You searched for: Author "Massuti, Bartomeu" Remove constraint Author: "Massuti, Bartomeu" Journal lung cancer (01695002) Remove constraint Journal: lung cancer (01695002)
11 results on '"Massuti, Bartomeu"'

Search Results

1. Trabectedin in patients with advanced non-small-cell lung cancer (NSCLC) with XPG and/or ERCC1 overexpression and BRCA1 underexpression and pretreated with platinum

2. Combination of gefitinib and olaparib versus gefitinib alone in EGFR mutant non-small-cell lung cancer (NSCLC): A multicenter, randomized phase II study (GOAL).

Catalog

Books, media, physical & digital resources

3. Alectinib for the treatment of pretreated RET-rearranged advanced NSCLC: Results of the ETOP ALERT-lung trial.

4. BRAF mutational status is associated with survival outcomes in locally advanced resectable and metastatic NSCLC.

5. Capmatinib plus nivolumab in pretreated patients with EGFR wild-type advanced non–small cell lung cancer.

6. Phase II clinical trial with metronomic oral vinorelbine and tri-weekly cisplatin as induction therapy, subsequently concomitant with radiotherapy (RT) in patients with locally advanced, unresectable, non-small cell lung cancer (NSCLC). Analysis of survival and value of ctDNA for patient selection

7. Oral vinorelbine versus etoposide with cisplatin and chemo-radiation as treatment in patients with stage III non-small cell lung cancer: A randomized phase II (RENO study).

8. First-line therapy and methylation status of CHFR in serum influence outcome to chemotherapy versus EGFR tyrosine kinase inhibitors as second-line therapy in stage IV non-small-cell lung cancer patients

9. Blood-based CHRNA3 single nucleotide polymorphism and outcome in advanced non-small-cell lung cancer patients

10. Cisplatin plus vinorelbine as first-line treatment for advanced non-small-cell lung cancer: Is a hemogram on day 8 essential?

11. Genetic testing for chemotherapy in non-small cell lung cancer